GMAB GENMAB A/S

BEARISH Impact: 4/10 Institutional Cluster
Horizon weeks Processed 3d 21h ago
Institutional cluster: 2 buyers, 4 sellers (mixed)

Executive Summary

An institutional cluster in GMAB shows mixed conviction: two passive funds (Fidelity, Schwab) added $21.8M in new holdings, while four institutions (including Citadel and three passive managers) reduced positions by $85.7M. The net selling pressure of ~$63.9M from the sellers, led by Citadel's near-exit of a $73.7M position, dominates the cluster signal and suggests caution despite the buying activity.

Key Financial Metrics

Direction
distributing
Buy Value
$37.4M
Sell Value
$151.1M
Net Flow
-$63.9M

Institutional Positions

Net institutional flow: -$63.9M

▲ Buyers (2)

InstitutionActionChangePosition ValueValue Δ
Fidelity ADD +64.5% $34.3M $20.3M
Schwab ADD +32.3% $3.1M $1.5M

▼ Sellers (4)

InstitutionActionChangePrev ValueValue Δ
Citadel NEAR_EXIT -98.6% $73.7M -$72.2M
UBS NEAR_EXIT -83.1% $10.0M -$7.5M
Morgan Stanley TRIM -37.9% $55.7M -$4.4M
BofA TRIM -42.2% $11.7M -$1.7M

Actionable Insight

The cluster is dominated by passive fund rebalancing on both sides, but Citadel's near-total exit of a large position is a notable active-manager signal. Monitor for any fundamental deterioration or catalyst that could explain the selling. The buying from Fidelity and Schwab is likely mechanical and does not offset the bearish signal from the sellers.

Key Facts

  • 2 buyers added $21.8M in new holdings (Fidelity +$20.3M, Schwab +$1.5M)
  • 4 sellers reduced positions by $85.7M (Citadel -$72.2M, UBS -$7.5M, Morgan Stanley -$4.4M, BofA -$1.7M)
  • Citadel executed a near-exit, reducing a $73.7M position to $1.6M (-98.6% of shares)
  • All buyers are mega-passive funds (likely index rebalancing), while sellers include one active quant (Citadel) and three passive managers
  • Net aggregate change: -$63.9M (sellers outweigh buyers by ~3:1 in dollar terms)

Financial Impact

Net institutional selling of ~$63.9M in Q3 2025, with total seller reductions of $85.7M versus buyer additions of $21.8M

institutional holdingsfloat allocation

Risk Factors

  • 13F data is 45+ days stale; positions may have been further adjusted since quarter-end
  • Passive fund activity may reflect index rebalancing rather than fundamental conviction
  • Historical reports on GMAB show negative T+20 performance (-12.88% on prior bullish call), suggesting the stock has been difficult to time

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
76% bullish (25 analysts)

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-GMAB-2025-Q3
3 reports for GMAB
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for GMAB — sortable, filterable
Type Now
Jun 11, 2026
3d ago
6-K
NEUTRAL ★ 2/10
$25.21 awaiting T+60awaiting T+60
Jun 11, 2026
3d ago
Institutional Cluster
BEARISH ★ 4/10
$24.48 awaiting T+60awaiting T+60
Feb 28, 2026
15w ago
Institutional Cluster
BULLISH ★ 7/10
$29.65 $26.89▼ −9.31%▼ −18.64%
Showing 3 of 3

US Market Status

Market Closed — Opens in 3h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access